Variant · Snv
GATA2 NM_032638.5(GATA2):c.445G>A (p.Gly149Arg)
CI-VAR-00059862Explore in graph →p.Gly149ArgNM_032638.5:c.445G>AClinVar 404080 rs753645971
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 404080 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Deafness-lymphedema-leukemia syndrome; Monocytopenia with susceptibility to infections; Acute myeloid leukemia; Myelodysplastic syndrome; GATA2-related disorder; GATA2 deficiency with susceptibility to MDS/AML | germline | 8 | Feb 01, 2026 | clinvar |